Contents
Download PDF
pdf Download XML
248113 Views
20041 Downloads
Share this article
Research Article | Volume 24 Issue 1 (, 2018) | Pages 66 - 73
Long-Term Clinical Outcomes of Silzone Era St. Jude Medical Mechanical Heart Valves
 ,
 ,
 ,
 ,
 ,
 ,
 ,
 ,
 ,
 ,
 ,
Under a Creative Commons license
PMID : -26182622
Published
Jan. 12, 2015
Abstract

Background and aim of the study: Since the voluntary recall of St. Jude Medical (SJM) Silzone impregnated heart valves, no large-scale study has examined their long-term outcomes.

Methods: Using Medicare-linked records from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (1993-2004), the clinical outcomes were evaluated through eight years among those patients who received SJM mechanical heart valves during the Silzone era (March 1998 to December 1999; n = 3,775), relative to those in both the pre-Silzone era (January 1993 to February 1998; n = 13,570) and the post-Silzone era (January 2000 to December 2004; n = 6,882). An inverse probability weighting was used to balance the observed differences in case mix.

Results: During the Silzone era, 79% of all implanted mechanical heart valves were manufactured by SJM. By eight years post-implantation, the most common adverse events in this Medicare-linked cohort (median age 71 years) were death (43.5%) and thromboembolism (14.7%), while valve reoperation (1.7%) and endocarditis (1.4%) were less common. Patients treated during the Silzone era experienced a lower associated risk of mortality to eight years than those in both the pre-Silzone era (adjusted hazards ratio (HR) 0.93, 95% confidence interval (CI) 0.88-0.98) and post-Silzone era (adjusted HR 0.92, CI 0.67-0.98), while the adjusted eight-year risks of reoperation, thromboembolism and endocarditis were similar across the three eras for the overall cohort and among both aortic valve and mitral valve patients.

Conclusion: Medicare patients who received SJM mechanical heart valves during the Silzone era experienced similar clinical outcomes as those treated before or after the Silzone era. These data do not substantiate continued public health concerns associated with Silzone era valve prostheses among older individuals.

 

 

 

How to cite: Brennan JM, Zhao Y, Williams J, O'Brien S, Dokholyan R, Gammie J, Edwards F, Loyo-Berrios N, Canos D, Gross T, Marinac-Dabic D, Peterson E. Long-Term Clinical Outcomes of Silzone Era St. Jude Medical Mechanical Heart Valves. J Heart Valve Dis. 2015 Jan;24(1):66-73. PMID: 26182622.

 
Keywords
Recommended Articles
Research Article
Cross Sectional Study on Nutritional Status and Prevalence of Anemia in Rural Adolescents
Published: 26/06/2013
Download PDF
Read Article
Research Article
To Study the Serum Homocysteine Profile Pattern in AMI & Ischaemic Stroke in Young Adults.
...
Published: 30/08/2025
Download PDF
Read Article
Research Article
Incidence, Clinical Profile, Complications and Outcome of Rodenticide Poisoning in Tertiary Care Hospital
...
Published: 26/08/2025
Download PDF
Read Article
Research Article
To Find Out of the Effects of Mother Nutrition Status on Birth Weight, Anthropometric Measurements of Full-Term Newborn
Published: 07/11/2022
Download PDF
Read Article
© Copyright Journal of Heart Valve Disease